Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least 25 kg
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
Merck opens first climate-neutral manufacturing facility in Ireland
Subscribe To Our Newsletter & Stay Updated
